JSPR
Jasper Therapeutics Inc
3.78%
$1.85 - $1.92
Feb 8th 2023 - Mar 22nd 2023
Jan, 5, 2023
It’s up 20% today and still at $0.60 pps Phase 3 p... See more
Jan, 4, 2023
$JSPR PHASE 2 SUCCESSFULLY COMPLETED AT $ENSC 🚀 🚀 ! !
IBRX
ImmunityBio Inc
-57.41%
$4.32 - $1.84
Feb 7th 2023 - Mar 21st 2023
Mar, 19, 2023
There is minimal "clinical" risk on the ... See more
Mar, 15, 2023
though much more expensive than chemical entities,... See more
TCBP
TC BioPharm Holdings Ltd
-46.03%
$5.67 - $3.06
Feb 7th 2023 - Mar 21st 2023
Mar, 9, 2023
They are extremely confident and hired people to e... See more
Mar, 6, 2023
but future is proving bright here via trials going... See more
Jan, 5, 2023
It’s up 20% today and still at $0.60 pps Phase 3 pipeline results in a few weeks
Jan, 4, 2023
$JSPR PHASE 2 SUCCESSFULLY COMPLETED AT $ENSC 🚀 🚀 ! !
Jan, 4, 2023
The study met the primary endpoint of safety and tolerability.
Mar, 19, 2023
There is minimal "clinical" risk on the BLA; it fulfilled all the endpoints with flying colors and looks safe.
Mar, 15, 2023
though much more expensive than chemical entities, are generally considered by health care providers and payers to be worth their cost — as long as the appropriate patients receive them and achieve the desired clinical outcomes.
Mar, 6, 2023
Dilution and CEO July trial is no bueno here 🤗 Puts look wonderful
Mar, 6, 2023
If you believe in the science and current studies than buying down here is an amazing opportunity that will deliver in time.
Mar, 4, 2023
Overall well-being health-related quality of life scores for patients treated with omidubicel showed clinical benefit compared to standard of care, the company said.”
Feb, 7, 2023
but with IBRX current pipeline, peer studies confirming the science, and pending PDUFA for N-803 + BCG I remain bullish.
Dec, 27, 2022
People who received the trial treatment lived with improved quality and longer.
Nov, 29, 2022
6) Good possibility of FDA approving our pancreatic cocktail for phase 3 (I think?).
Nov, 22, 2022
because the trial results show that lives are improved.
Mar, 9, 2023
They are extremely confident and hired people to enter the big market of the USA , they have not stopped other trials they are in !!!!
Mar, 6, 2023
but future is proving bright here via trials going into phase 2, old news here… let’s stay optimistic here, enjoy the ride. 🍻🍻
Feb, 13, 2023
$TCBP sell now and miss huge news of phase 2b/3 results of 5 patients.. which will definitely be GREAT
Feb, 11, 2023
Clinical trials have already shown incredible results and a full trial with 37 patients in ACHIEVE kicks off very soon.
Feb, 5, 2023
main man owns 30 percent and he made a billion on moderna so we have s ’ pedegree’ this one should double or triple easily on good phase III!
Feb, 3, 2023
Successful 2b/3 trial for cancer drug.
Jan, 31, 2023
$TCBP they are in Phase 2/3.. everything is promising for the new drug it seems
Jan, 28, 2023
Read the results from earlier studies. Astounding!!
Jan, 26, 2023
Fast tracked, phase 3.